Clinical trial / 2001
An allicin-containing garlic supplement reduced common cold incidence and symptom duration.
In a 12-week trial, 146 volunteers took either an allicin-containing garlic pill or a placebo daily. Participants receiving garlic experienced significantly fewer colds than those on placebo (24 versus 65, P < .001). The garlic group also recorded fewer total days with viral illness (111 versus 366, P < .05) and shorter average symptom duration (1.52 versus 5.01 days, P < .001).
- Study type
- Randomized controlled trial
- Who was studied
- 146 volunteers
- What was measured
- Common cold incidence, viral challenge days, and symptom duration
THE PAPER
Preventing the common cold with a garlic supplement: a double-blind, placebo-controlled survey.
Josling P. Adv Ther, 2001.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.